[1]
Nesrin ŞEN and Mehmet Engin TEZCAN, “Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19”, Archives of Rheumatology, vol. 36, no. 1, pp. 142–143, Mar. 2021.